Stormy is an Expert Scientist and the Section Head of Neurogenomics in the Neuroscience and Rare Disease Research department at F. Hoffmann-La Roche.  Stormy earner her Ph.D. in Medical Sciences-Genetics from the University of Florida in the lab of Dr. Cami Brannan, studying the regulation of gene expression at the Angelman/Prader-Willi locus in mouse. She completed postdoctoral training in Stem Cells and Genetics at the University of North Carolina at Chapel Hill in the lab of Dr. Terry Magnuson and at University of Connecticut School of Medicine in the lab of Dr. Marc Lalande.  During her 14 years as an Assistant or Associate Professor at University of Connecticut School of Medicine, her lab generated and used induced pluripotent stem cells to interrogate gene regulation within the chromosome 15q11-q13 region and to test therapeutic approaches for Angelman, Dup15q, and Prader-Willi syndromes using human neuron models derived from patient samples.  At Roche, Stormy’s lab focuses on therapeutic development for Angelman and Dup15q syndromes. Stormy is a Senior Principal Scientist and the Section Head of Neurogenomics in the Neuroscience and Rare Disease Research department at F. Hoffmann-La Roche.  Stormy earner her Ph.D. in Medical Sciences-Genetics from the University of Florida in the lab of Dr. Cami Brannan, studying the regulation of gene expression at the Angelman/Prader-Willi locus in mouse. She completed postdoctoral training in Stem Cells and Genetics at the University of North Carolina at Chapel Hill in the lab of Dr. Terry Magnuson and at University of Connecticut School of Medicine in the lab of Dr. Marc Lalande.  During her 14 years as an Assistant or Associate Professor at University of Connecticut School of Medicine, her lab generated and used induced pluripotent stem cells to interrogate gene regulation within the chromosome 15q11-q13 region and to test therapeutic approaches for Angelman, Dup15q, and Prader-Willi syndromes using human neuron models derived from patient samples.  At Roche, Stormy’s lab and section focuses on therapeutic development for neurological disorders, including Angelman and Dup15q syndromes.